Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11482)
All Articles published online
|
Publishing Process of This Article
|
Jun 27, 2014 (publication date) through Sep 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bruminhent J, Razonable RR. Management of cytomegalovirus infection and disease in liver transplant recipients. World J Hepatol 2014; 6(6): 370-383 [PMID: 25018848 DOI: 10.4254/wjh.v6.i6.370] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i6/370.htm |
| Number | Citing Articles |
| 1 |
A. Verma, K. Palaniswamy, G. Cremonini, N. Heaton, A. Dhawan. Late cytomegalovirus infection in children: High incidence of allograft rejection and hepatitis in donor negative and seropositive liver transplant recipients. Pediatric Transplantation 2017; 21(3) doi: 10.1111/petr.12879
|
| 2 |
Brian W McSteen, Xiao-Han Ying, Catherine Lucero, Arun B Jesudian. Viral etiologies of acute liver failure. World Journal of Virology 2024; 13(3): 97973 doi: 10.5501/wjv.v13.i3.97973
|
| 3 |
Munehiro Furuichi, Takeo Fujiwara, Akinari Fukuda, Mureo Kasahara, Isao Miyairi. Fulminant Hepatic Failure as a Risk Factor for Cytomegalovirus Infection in Children Receiving Preemptive Therapy After Living Donor Liver Transplantation. Transplantation 2016; 100(11): 2404 doi: 10.1097/TP.0000000000001435
|
| 4 |
Yao-Tang Lin, James Prendergast, Finn Grey, Felicia Goodrum. The host ubiquitin-dependent segregase VCP/p97 is required for the onset of human cytomegalovirus replication. PLOS Pathogens 2017; 13(5): e1006329 doi: 10.1371/journal.ppat.1006329
|
| 5 |
Karen C. Tsai, Lara A. Danziger-Isakov, David B. Banach. Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention. Current Infectious Disease Reports 2016; 18(2) doi: 10.1007/s11908-015-0511-8
|
| 6 |
Danielle N. Brown, Ramya Kollipara, Stephen Tyring. Oral Signs of Systemic Disease. 2019; : 145 doi: 10.1007/978-3-030-10863-2_8
|
| 7 |
Aslıhan DEMİREL, Kezban NUR PİLANCI, Neşe İNAN, Nur Efe İRİS, Arzu BAYGÜL, Gökhan DEMİR, Emine SÖNMEZ. Investigation of the effect of chemotherapy on cytomegalovirus reactivity in patients with solid organ tumors. The European Research Journal 2021; 7(1): 38 doi: 10.18621/eurj.573407
|
| 8 |
Federica Zavaglio, Irene Cassaniti, Piera d’Angelo, Paola Zelini, Giuditta Comolli, Marilena Gregorini, Teresa Rampino, Lucia Del Frate, Federica Meloni, Carlo Pellegrini, Massimo Abelli, Elena Ticozzelli, Daniele Lilleri, Fausto Baldanti. Immune Control of Human Cytomegalovirus (HCMV) Infection in HCMV-Seropositive Solid Organ Transplant Recipients: The Predictive Role of Different Immunological Assays. Cells 2024; 13(16): 1325 doi: 10.3390/cells13161325
|
| 9 |
Catherine Rowan, Ciaran Judge, Mary D. Cannon, Garret Cullen, Hugh E. Mulcahy, Elizabeth Ryan, Cillian F. De Gascun, Glen A. Doherty. Severe Symptomatic Primary CMV Infection in Inflammatory Bowel Disease Patients with Low Population Seroprevalence. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/1029401
|
| 10 |
Aiman Ghufran, Michael R. Lucey. Zakim and Boyer's Hepatology. 2018; : 769 doi: 10.1016/B978-0-323-37591-7.00052-5
|
| 11 |
Sanjay K. Yadav, Sanjiv Saigal, Narendra S. Choudhary, Sujit Saha, Navin Kumar, Arvinder S. Soin. Cytomegalovirus Infection in Liver Transplant Recipients: Current Approach to Diagnosis and Management. Journal of Clinical and Experimental Hepatology 2017; 7(2): 144 doi: 10.1016/j.jceh.2017.05.011
|
| 12 |
Teresa Da Cunha, George Y. Wu. Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts. Journal of Clinical and Translational Hepatology 2021; 0(000): 1 doi: 10.14218/JCTH.2020.00088
|
| 13 |
Marzieh Jamalidoust, Mandana Namayandeh, Gholamreza Pouladfar, Mazyar Ziyaeyan. Post-Liver Transplant Cytomegalovirus (CMV) Reactivation, Graft, and Patient Survival Rates in Iranian Population. Jundishapur Journal of Microbiology 2021; 14(3) doi: 10.5812/jjm.112775
|
| 14 |
Chien-Ting Lin, Po-Ren Hsueh, Shang-Ju Wu, Ming Yao, Bor-Sheng Ko, Chi-Cheng Li, Cheng-An Hsu, Jih-Luh Tang, Hwei-Fang Tien. Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial. Biology of Blood and Marrow Transplantation 2018; 24(11): 2310 doi: 10.1016/j.bbmt.2018.07.013
|
| 15 |
Yao-Tang Lin, Stephen Chiweshe, Dominique McCormick, Anna Raper, Arthur Wickenhagen, Victor DeFillipis, Eleanor Gaunt, Peter Simmonds, Sam J. Wilson, Finn Grey, Eain A. Murphy. Human cytomegalovirus evades ZAP detection by suppressing CpG dinucleotides in the major immediate early 1 gene. PLOS Pathogens 2020; 16(9): e1008844 doi: 10.1371/journal.ppat.1008844
|
| 16 |
Alina M. Allen, Jayant A. Talwalkar. Zakim and Boyer's Hepatology. 2018; : 556 doi: 10.1016/B978-0-323-37591-7.00038-0
|
| 17 |
Juhye Roh, Sinyoung Kim, Eunmin Kwak, Jungyong Park, Younhee Park. Performance evaluation of the Roche cobas 6800 system for quantifying cytomegalovirus DNA in plasma and urine samples. Journal of Clinical Virology 2021; 138: 104816 doi: 10.1016/j.jcv.2021.104816
|
| 18 |
Andrew D. Clouston, Stefan G. Hübscher. Macsween's Pathology of the Liver. 2018; : 880 doi: 10.1016/B978-0-7020-6697-9.00014-5
|
| 19 |
Jackrapong Bruminhent, Charat Thongprayoon, Ross A. Dierkhising, Walter K. Kremers, Elitza S. Theel, Raymund R. Razonable. Risk factors for cytomegalovirus reactivation after liver transplantation: Can pre‐transplant cytomegalovirus antibody titers predict outcome?. Liver Transplantation 2015; 21(4): 539 doi: 10.1002/lt.24078
|
| 20 |
Hao‐Chien Hung, Po‐Jung Hsu, Jin‐Chiao Lee, Yu‐Chao Wang, Chih‐Hsien Cheng, Tsung‐Han Wu, Ting‐Jung Wu, Hong‐Shiue Chou, Kun‐Ming Chan, Wei‐Chen Lee, Chen‐Fang Lee. Plasma cytomegalovirus DNA load predicts outcomes in liver transplant recipients. Immunity, Inflammation and Disease 2021; 9(1): 134 doi: 10.1002/iid3.371
|
| 21 |
Ângela Carvalho-Gomes, Almudena Cubells, Carmina Pallarés, Francisca Corpas-Burgos, Marina Berenguer, Victoria Aguilera, F. Xavier López-Labrador. Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation. Cellular Immunology 2022; 371: 104455 doi: 10.1016/j.cellimm.2021.104455
|
| 22 |
Y. Kawano, K. Mizuta, Y. Sanada, T. Urahashi, Y. Ihara, N. Okada, N. Yamada, H. Sasanuma, Y. Sakuma, N. Taniai, H. Yoshida, H. Kawarasaki, Y. Yasuda, E. Uchida. Risk Factors of Cytomegalovirus Infection After Pediatric Liver Transplantation. Transplantation Proceedings 2014; 46(10): 3543 doi: 10.1016/j.transproceed.2014.09.150
|
| 23 |
Emanuele Nicastro, Sara Giovannozzi, Paola Stroppa, Valeria Casotti, Anna Paola Callegaro, Alessandra Tebaldi, Claudio Farina, Michele Colledan, Lorenzo D'Antiga. Effectiveness of Preemptive Therapy for Cytomegalovirus Disease in Pediatric Liver Transplantation. Transplantation 2017; 101(4): 804 doi: 10.1097/TP.0000000000001531
|
| 24 |
Manasvi Gupta, Gaurav Manek, Kaitlyn Dombrowski, Rakhi Maiwall. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World Journal of Meta-Analysis 2021; 9(6): 522-542 doi: 10.13105/wjma.v9.i6.522
|
| 25 |
Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Young Eun Ha, Dong Hyun Sinn, Gyu-Seong Choi, Kyong Ran Peck, Suk-Koo Lee, Kwan Man. Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients. PLOS ONE 2015; 10(5): e0123554 doi: 10.1371/journal.pone.0123554
|
| 26 |
Michiko Morishita, Ken-Ei Sada, Yoshinori Matsumoto, Keigo Hayashi, Yosuke Asano, Sumie Hiramatsu Asano, Keiji Ohashi, Yoshia Miyawaki, Eri Katsuyama, Haruki Watanabe, Tomoko Kawabata, Jun Wada, Gianluigi Zaza. Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis. PLOS ONE 2019; 14(7): e0218705 doi: 10.1371/journal.pone.0218705
|
| 27 |
Ajit P. Limaye, Corinna La Rosa, Jeff Longmate, Don J. Diamond. Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients. Transplantation 2016; 100(1): 210 doi: 10.1097/TP.0000000000000816
|
| 28 |
Jonathan M. Fenkel, Dina L. Halegoua-DeMarzio. Management of the Liver Transplant Recipient. Medical Clinics of North America 2016; 100(3): 477 doi: 10.1016/j.mcna.2016.01.001
|
| 29 |
Ajay S. Shinde, Dharmesh Kapoor. Infections After Liver Transplant -Timeline, Management and Prevention. Journal of Clinical and Experimental Hepatology 2024; 14(3): 101316 doi: 10.1016/j.jceh.2023.101316
|
| 30 |
Cornelius Johannes Busch, Benedikt Hermann Siegler, Heike Werle, Christoph Lichtenstern, Thomas Bruckner, Alexandra Heininger, Arianeb Mehrabi, Karl Heinz Weiss, Markus Alexander Weigand, Marcel Hochreiter. Risk factors for early viral infections after liver transplantation. Langenbeck's Archives of Surgery 2018; 403(4): 509 doi: 10.1007/s00423-018-1672-3
|
| 31 |
|
| 32 |
Jorge Arroyo‐Orvañanos, José‐Alejandro Hernández‐Plata, Rosa Erro‐Aboytia, Jaime Nieto‐Zermeño, Alfonso Reyes‐López, Gustavo Varela‐Fascinetto. Cytomegalovirus infection and disease in pediatric liver transplantation: Burden of disease under a preemptive therapy approach. Pediatric Transplantation 2023; 27(1) doi: 10.1111/petr.14356
|
| 33 |
Hannah Nam, Kathy M. Nilles, Josh Levitsky, Michael G. Ison. Donor-derived Viral Infections in Liver Transplantation. Transplantation 2018; 102(11): 1824 doi: 10.1097/TP.0000000000002326
|
| 34 |
Emanuele Nicastro, Lorenzo D’Antiga. Pediatric Hepatology and Liver Transplantation. 2019; : 593 doi: 10.1007/978-3-319-96400-3_34
|
| 35 |
Daniela S. Allende, Lisa M. Yerian, Deepa T. Patil. Gastrointestinal and Liver Pathology. 2024; : 657 doi: 10.1016/B978-0-323-52794-1.00020-1
|
| 36 |
Zeynep Burcin Yilmaz, Funda Memisoglu, Sami Akbulut. Management of cytomegalovirus infection after liver transplantation. World Journal of Transplantation 2024; 14(3): 93209 doi: 10.5500/wjt.v14.i3.93209
|
| 37 |
Colin Anderson‐Smits, Erin R. Baker, Ishan Hirji. Coinfection rates and clinical outcome data for cytomegalovirus and Epstein‐Barr virus in post‐transplant patients: A systematic review of the literature. Transplant Infectious Disease 2020; 22(6) doi: 10.1111/tid.13396
|
| 38 |
Chen-Hsuin Lee, Finn Grey. Systems Virology and Human Cytomegalovirus: Using High Throughput Approaches to Identify Novel Host-Virus Interactions During Lytic Infection. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.00280
|
| 39 |
Atibordee Meesing, Raymund R. Razonable. New Developments in the Management of Cytomegalovirus Infection After Transplantation. Drugs 2018; 78(11): 1085 doi: 10.1007/s40265-018-0943-1
|
| 40 |
Arno Kornberg. Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation. World Journal of Hepatology 2015; 7(11): 1494-1508 doi: 10.4254/wjh.v7.i11.1494
|
| 41 |
Christophe Camus, Mélanie Poinot, Charlotte Pronier, Michel Rayar, Anne Le Neillon, Marianne Latournerie, Gisèle Lagathu, Matthieu Revest. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transplant Infectious Disease 2024; 26(3) doi: 10.1111/tid.14282
|
| 42 |
Krishnan Nair Balakrishnan, Ashwaq Ahmed Abdullah, Jamilu Abubakar Bala, Faez Firdaus Abdullah Jesse, Che Azurahanim Che Abdullah, Mustapha Mohamed Noordin, Mohd Lila Mohd-Azmi. Multiple gene targeting siRNAs for down regulation of Immediate Early-2 (Ie2) and DNA polymerase genes mediated inhibition of novel rat Cytomegalovirus (strain All-03). Virology Journal 2020; 17(1) doi: 10.1186/s12985-020-01436-5
|
| 43 |
|
| 44 |
Oksana Narovlyanskaya, Elizabeth J. Winokur. Viral Myocarditis. Dimensions of Critical Care Nursing 2020; 39(2): 75 doi: 10.1097/DCC.0000000000000402
|
| 45 |
Matthew A. Odenwald, Hannah F. Roth, Anesia Reticker, Maria Segovia, Anjana Pillai. Evolving challenges with long‐term care of liver transplant recipients. Clinical Transplantation 2023; 37(10) doi: 10.1111/ctr.15085
|
| 46 |
Warunyu Namsiripongpun, Surasak Kantachuvesiri, Jackrapong Bruminhent. Utility of the Interferon-Gamma Enzyme-Linked Immunosorbent Spot Assay to Predict Risk of Cytomegalovirus Infection in Kidney Transplant Recipients. Transplant International 2024; 36 doi: 10.3389/ti.2023.11527
|
| 47 |
Angela R. Shih, Bita V. Naini, Maria Westerhoff, Lindsay Alpert, Ricard Masia, Joseph Misdraji. Cytomegalovirus Hepatitis in Allograft Livers May Show Histologic Features of Acute Cellular Rejection. Archives of Pathology & Laboratory Medicine 2023; 147(6): 655 doi: 10.5858/arpa.2021-0551-OA
|
| 48 |
T. Ambrose, L.M. Sharkey, J. Louis-Auguste, C.S. Rutter, S. Duncan, S. English, E. Gkrania-Klotsas, A. Carmichael, J.M. Woodward, N. Russell, D. Massey, A. Butler, S. Middleton. Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation. Transplantation Proceedings 2016; 48(2): 492 doi: 10.1016/j.transproceed.2015.09.070
|
| 49 |
P. Czarnecka, K. Czarnecka, O. Tronina, M. Durlik. Cytomegalovirus Disease After Liver Transplant—A Description of a Treatment-Resistant Case: A Case Report and Literature Review. Transplantation Proceedings 2018; 50(10): 4015 doi: 10.1016/j.transproceed.2018.05.014
|
| 50 |
Smaranda Gliga, Melanie Fiedler, Theresa Dornieden, Anne Achterfeld, Andreas Paul, Peter A. Horn, Kerstin Herzer, Monika Lindemann. Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients. Vaccines 2021; 9(2): 88 doi: 10.3390/vaccines9020088
|
| 51 |
Robert Breitkopf, Benedikt Treml, Zoran Bukumiric, Nicole Innerhofer, Margot Fodor, Aleksandra Radovanovic Spurnic, Sasa Rajsic. Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis. Journal of Clinical Medicine 2023; 12(16): 5198 doi: 10.3390/jcm12165198
|
| 52 |
K. Mumtaz, N. Faisal, S. Husain, A. Morillo, E.L. Renner, P.S. Shah. Universal Prophylaxis or Preemptive Strategy for Cytomegalovirus Disease After Liver Transplantation: A Systematic Review and Meta-Analysis. American Journal of Transplantation 2015; 15(2): 472 doi: 10.1111/ajt.13044
|
| 53 |
Atibordee Meesing, Roshini S. Abraham, Raymund R. Razonable. Clinical Correlation of Cytomegalovirus Infection With CMV-specific CD8+ T-cell Immune Competence Score and Lymphocyte Subsets in Solid Organ Transplant Recipients. Transplantation 2019; 103(4): 832 doi: 10.1097/TP.0000000000002396
|
| 54 |
Leslie Kobayashi, Emily Cantrell. Surgical Critical Care and Emergency Surgery. 2018; : 209 doi: 10.1002/9781119317913.ch22
|
| 55 |
Jassin Rashidi‐Alavijeh, Jens Christoph Crämer, Helena Louisa Sauter, Katharina Willuweit, Katja Straub, Heiner Wedemeyer, Kerstin Herzer. Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant. Transplant Infectious Disease 2021; 23(3) doi: 10.1111/tid.13553
|
| 56 |
D. O. Efremov, O. A. Gerasimova, K. V. Kozlov, I. A. Gabdrakhmanov, K. V. Zhdanov. Cytomegalovirus infection in patients after orthotopic liver transplantation (clinical report). Journal Infectology 2019; 11(4): 148 doi: 10.22625/2072-6732-2019-11-4-148-152
|
| 57 |
Norrapat Onpoaree, Anapat Sanpavat, Palittiya Sintusek. Cytomegalovirus infection in liver-transplanted children. World Journal of Hepatology 2022; 14(2): 338-353 doi: 10.4254/wjh.v14.i2.338
|
| 58 |
Andrew D. Clouston, Stefan G. Hübscher. MacSween's Pathology of the Liver. 2024; : 947 doi: 10.1016/B978-0-7020-8228-3.00014-4
|